Temozolomide Market by Clinical Application, by Distribution Channel, by Region, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Temozolomide Market by Clinical Application, by Distribution Channel, by Region, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Description:

The global temozolomide market size is accounted to register a significant CAGR of 2.5% during the forecast period 2021 to 2027 and expected to reach over USD 220 million by 2027. The increasing incidence of brain cancer around the world is a primary factor to drive the market growth. According to the information shared by the American Cancer Society, 308,102 new cases have reported as brain and nervous system cancer in 2020 around the world. Furthermore, the market is accelerated by the effective implementation of treatment guidelines related to the management and treatment of malignant brain tumors. Temozolomide is classified as an antinoplastic drug widely used by neurologists for the treatment of refractory anaplastic astrocytoma. – PowerPoint PPT presentation

Number of Views:35
Slides: 9
Provided by: uttam217

less

Transcript and Presenter's Notes

Title: Temozolomide Market by Clinical Application, by Distribution Channel, by Region, Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027


1
Global Temozolomide Market
  • Temozolomide Market by Clinical Application, by
    Distribution Channel, by Region, Size, Share,
    Growth, Global Trends, Industry Analysis and
    Forecast to 2027

To know more about this study, request a free
sample report _at_ https//www.researchcorridor.com/r
equest-sample/?id82156
2
Global Temozolomide Market
  • Market Synopsis
  • The global temozolomide market size is
    accounted to register a significant CAGR of 2.5
    during the forecast period 2021 to 2027 and
    expected to reach over USD 220 million by 2027.
    The increasing incidence of brain cancer around
    the world is a primary factor to drive the market
    growth. According to the information shared by
    the American Cancer Society, 308,102 new cases
    have reported as brain and nervous system cancer
    in 2020 around the world. Furthermore, the market
    is accelerated by the effective implementation of
    treatment guidelines related to the management
    and treatment of malignant brain tumors.
    Temozolomide is classified as an antinoplastic
    drug widely used by neurologists for the
    treatment of refractory anaplastic astrocytoma.

3
Global Temozolomide Market
  • Research Methoddolgy

4
Global Temozolomide Market
  • Global Temozolomide Market Segmentation
  • By Clinical Application
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Others
  • By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

5
Global Temozolomide Market
  • Global Temozolomide Market Segmentation
  • By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

6
Global Temozolomide Market
  • List of Key Companies
  • Accord Healthcare, Inc.
  • Apotex Corporation
  • Merck KGaA
  • Cipla Limited.
  • Teva Pharmaceutical Industries Limited.
  • Schering-Plough Corporation
  • Mayne Pharma Group
  • Alvogen
  • Mylan Pharmaceutical Industries Limited
  • Sandoz, Inc.

7
Global Temozolomide Market
  • By Region

8
Global Temozolomide Market
  • Media Contact
  • Company Name Research CorridorContact
    Person Mr. Vijendra SinghEmail
    sales_at_researchcorridor.comContact no 1
    520-686-7060
  • Follow Us
Write a Comment
User Comments (0)
About PowerShow.com